484 related articles for article (PubMed ID: 26830221)
1. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB
Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221
[TBL] [Abstract][Full Text] [Related]
2. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
4. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Feng Y; Huang X; Li L; Chen Z
Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
[TBL] [Abstract][Full Text] [Related]
6. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography.
Traub SJ; Mitchell AM; Jones AE; Tang A; O'Connor J; Nelson T; Kellum J; Shapiro NI
Ann Emerg Med; 2013 Nov; 62(5):511-520.e25. PubMed ID: 23769807
[TBL] [Abstract][Full Text] [Related]
8. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V
Ann Intern Med; 2009 Nov; 151(9):631-8. PubMed ID: 19884624
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhao SJ; Zhong ZS; Qi GX; Tian W
Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
[TBL] [Abstract][Full Text] [Related]
13. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
[TBL] [Abstract][Full Text] [Related]
14. Measures used to treat contrast-induced nephropathy: overview of reviews.
Kwok CS; Pang CL; Yeong JK; Loke YK
Br J Radiol; 2013 Jan; 86(1021):20120272. PubMed ID: 23239696
[TBL] [Abstract][Full Text] [Related]
15. Prevention of contrast-induced nephropathy: a single center randomized study.
Castini D; Lucreziotti S; Bosotti L; Salerno Uriarte D; Sponzilli C; Verzoni A; Lombardi F
Clin Cardiol; 2010 Mar; 33(3):E63-8. PubMed ID: 20127900
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis.
Zhang B; Liang L; Chen W; Liang C; Zhang S
BMJ Open; 2015 Mar; 5(3):e006989. PubMed ID: 25783425
[TBL] [Abstract][Full Text] [Related]
17. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
Bouzas-Mosquera A; Recio-Mayoral A
Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455
[No Abstract] [Full Text] [Related]
18. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
Habib M; Hillis A; Hammad A
Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):55-61. PubMed ID: 26787567
[TBL] [Abstract][Full Text] [Related]
19. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
Leone AM; De Caterina AR; Sciahbasi A; Aurelio A; Basile E; Porto I; Trani C; Burzotta F; Niccoli G; Mongiardo R; Mazzari MA; Buffon A; Panocchia N; Romagnoli E; Lioy E; Rebuzzi AG; Crea F
EuroIntervention; 2012 Nov; 8(7):839-47. PubMed ID: 23171803
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]